Treatments for dysarthria in Parkinson's disease - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue The Lancet Neurology Année : 2004

Treatments for dysarthria in Parkinson's disease

Résumé

Dysarthria in Parkinson’s disease can be characterised by monotony of pitch and loudness, reduced stress, variable rate, imprecise consonants, and a breathy and harsh voice. Use of levodopa to replenish dopamine concentrations in the striatum seems to improve articulation, voice quality, and pitch variation, although some studies show no change in phonatory parameters. Traditional speech therapy can lead to improvement of dysarthria, and intensive programmes have had substantial beneficial effects on vocal loudness. Unilateral surgical lesions of subcortical structures are variably effective for the alleviation of dysarthria, whereas bilateral procedures typically lead to worsening of speech production. Among deep brain stimulation procedures, only stimulation of the subthalamic nucleus improves some motor components of speech although intelligibility seems to decrease after surgery. Due to the variable treatment effects on parkinsonian speech, management of dysarthria is still challenging for the clinician and should be discussed with the patient.

Dates et versions

hal-01933514 , version 1 (23-11-2018)

Identifiants

Citer

Serge Pinto, Canan Ozsancak, Elina Tripoliti, Stéphane Thobois, Patricia Limousin-Dowsey, et al.. Treatments for dysarthria in Parkinson's disease. The Lancet Neurology, 2004, 3 (9), pp.547 - 556. ⟨10.1016/S1474-4422(04)00854-3⟩. ⟨hal-01933514⟩
116 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More